董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Thomas P. Mac Mahon | 男 | Director | 79 | 20.90万美元 | 未持股 | 2017-05-01 |
| Thomas P. Gerrity | 男 | Director | 84 | 20.65万美元 | 未持股 | 2017-05-01 |
| Frank E. Collins | 男 | Director | 63 | 21.05万美元 | 未持股 | 2017-05-01 |
| W. Robert Dahl, Jr. | 男 | Director | 60 | 20.80万美元 | 未持股 | 2017-05-01 |
| Marjorie W. Dorr | 女 | Director | 55 | 20.80万美元 | 未持股 | 2017-05-01 |
| Geoffrey G. Meyers | 男 | Director, Chairman | 73 | 30.05万美元 | 未持股 | 2017-05-01 |
| Robert A. Oakley | 男 | Director | 70 | 22.30万美元 | 未持股 | 2017-05-01 |
| Gregory S. Weishar | 男 | Chief Executive Officer and Director | 62 | 435.81万美元 | 未持股 | 2017-05-01 |
| Patrick G. LePore | 男 | Director | 62 | 19.50万美元 | 未持股 | 2017-05-01 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Robert E. Dries | 男 | Executive Vice President and Chief Financial Officer | 50 | 未披露 | 未持股 | 2017-05-01 |
| Gregory S. Weishar | 男 | Chief Executive Officer and Director | 62 | 435.81万美元 | 未持股 | 2017-05-01 |
| Thomas A. Caneris | 男 | Senior Vice President, General Counsel and Secretary | 54 | 99.19万美元 | 未持股 | 2017-05-01 |
| Robert A. McKay | 男 | Senior Vice President of Purchasing and Trade Relations | 55 | 85.00万美元 | 未持股 | 2017-05-01 |
| Berard E. Tomassetti | 男 | Senior Vice President and Chief Accounting Officer | 61 | 53.19万美元 | 未持股 | 2017-05-01 |
| Suresh Vishnubhatla | 男 | Executive Vice President of Long-term Care Operations | 48 | 129.49万美元 | 未持股 | 2017-05-01 |
董事简历
中英对照 | 中文 | 英文- Thomas P. Mac Mahon
-
Thomas P. Mac Mahon自2007年1月31日担任公司董事。2007年7月31日至2010年12月31日，他担任董事会主席，现是公司薪酬委员会主席。自1995年， Mac Mahon担任美国控股公司LabCorp董事。此外，2007年1月至2009年5月他担任LabCorp董事会非执行主席；1996年4月至2006年12月任董事会执行主席；1995年4月任董事会副主席。1997年1月至2006年12月退休，Mac Mahon在 LabCorp.担任总裁、首席执行官以及行政管理委员会成员。他曾于1993年至1996年12月任罗氏医疗股份有限公司高级副总裁；1988年至1996年12月任罗氏诊断集团总裁兼执行委员会董事和成员。Mac Mahon 现任快捷药方股份有限公司董事及公司治理委员会主席，也是SynapDx公司和Aushon Biosystems股份有限公司董事会成员。
Thomas P. Mac Mahon was elected a director of Express Scripts in March 2001 and has served as Lead Independent Director since May 2008. Thomas P. Mac Mahon has served as a director since July 31 2007 and Chairman of the Compensation Committee since 2012 in addition to serving as Chairman of the Compensation Committee from July 2007 to February 2008. From 1995 to April 2013 Mr. Mac Mahon served as a director of Laboratory Corporation of America Holdings "LabCorp". In addition, Mr. Mac Mahon served as a non-executive Chairman of the Board of LabCorp from January 2007 to May 2009; and Executive Chairman of the Board from April 1996 to December 2006. From January 1997 until his retirement in December, 2006 Mr. Mac Mahon served as President and Chief Executive Officer. Mr. Mac Mahon was Senior Vice President or Hoffmann La Roche, Inc. from 1993 to December 1996 and President of Roche Diagnostics Group and a director and member of the Executive Committee of Hoffmann La Roche from 1988 to December 1996. Mr. Mac Mahon is a director and Corporate Governance Committee Chairperson of Express Scripts, Inc. and is a member of the Board of three private companies, SynapDx Corporation, Aushon BiosyStems, Inc. and Ortho Clinical Diagnostics. - Thomas P. Mac Mahon自2007年1月31日担任公司董事。2007年7月31日至2010年12月31日，他担任董事会主席，现是公司薪酬委员会主席。自1995年， Mac Mahon担任美国控股公司LabCorp董事。此外，2007年1月至2009年5月他担任LabCorp董事会非执行主席；1996年4月至2006年12月任董事会执行主席；1995年4月任董事会副主席。1997年1月至2006年12月退休，Mac Mahon在 LabCorp.担任总裁、首席执行官以及行政管理委员会成员。他曾于1993年至1996年12月任罗氏医疗股份有限公司高级副总裁；1988年至1996年12月任罗氏诊断集团总裁兼执行委员会董事和成员。Mac Mahon 现任快捷药方股份有限公司董事及公司治理委员会主席，也是SynapDx公司和Aushon Biosystems股份有限公司董事会成员。
- Thomas P. Mac Mahon was elected a director of Express Scripts in March 2001 and has served as Lead Independent Director since May 2008. Thomas P. Mac Mahon has served as a director since July 31 2007 and Chairman of the Compensation Committee since 2012 in addition to serving as Chairman of the Compensation Committee from July 2007 to February 2008. From 1995 to April 2013 Mr. Mac Mahon served as a director of Laboratory Corporation of America Holdings "LabCorp". In addition, Mr. Mac Mahon served as a non-executive Chairman of the Board of LabCorp from January 2007 to May 2009; and Executive Chairman of the Board from April 1996 to December 2006. From January 1997 until his retirement in December, 2006 Mr. Mac Mahon served as President and Chief Executive Officer. Mr. Mac Mahon was Senior Vice President or Hoffmann La Roche, Inc. from 1993 to December 1996 and President of Roche Diagnostics Group and a director and member of the Executive Committee of Hoffmann La Roche from 1988 to December 1996. Mr. Mac Mahon is a director and Corporate Governance Committee Chairperson of Express Scripts, Inc. and is a member of the Board of three private companies, SynapDx Corporation, Aushon BiosyStems, Inc. and Ortho Clinical Diagnostics.
- Thomas P. Gerrity
-
Thomas P. Gerrity，于1990年至1999年担任宾夕法尼亚大学沃顿商学院（The Wharton School of the University of Pennsylvania）院长，并是沃顿商学院（Wharton）管理学教授。1999年他担任担任沃顿商学院（Wharton）名誉退休院长并成为沃顿商学院（Wharton）Joseph Aresty管理学教授。在此之前，他创立了The Index Group公司并于1969年至1988年担任主席和CEO，该公司专门从事信息技术策略与管理、公司策略管理和商业重组等。他于2007年担任PharMerica Corporation公司董事。他于1990年之2010年担任Sunoco, Inc.公司董事，2003年至2008年担任Hercules, Inc.公司董事。
Thomas P. Gerrity has served as a director since July 31 2007. Mr. Gerrity serves as a member of the Compensation Committee and the Nominating and Corporate Governance Committee of the Board. Mr. Gerrity was the Dean of the Wharton School of the University of Pennsylvania from July 1990 to June 1999. Since then he has been Professor of Management and Dean Emeritus at the Wharton School of the University of Pennsylvania. Mr. Gerrity also serves as a director of Actua Corporation ACTA, since 1998 and served as a member of the Corporation of the Massachusetts Institute of Technology from 2001-2011. Mr. Gerrity is the Chairman of the Board and General Partner of the Arden Fund I and Fund II, a private real estate investment fund managed by the Arden Group in Philadelphia, Pennsylvania. Mr. Gerrity served as a director of Sunoco, Inc. Mr. Gerrity was the founder and Chief Executive Officer for 19 years of The Index Group, a leader in consulting to many corporations regarding IT strategy and overall corporate strategy and change management. - Thomas P. Gerrity，于1990年至1999年担任宾夕法尼亚大学沃顿商学院（The Wharton School of the University of Pennsylvania）院长，并是沃顿商学院（Wharton）管理学教授。1999年他担任担任沃顿商学院（Wharton）名誉退休院长并成为沃顿商学院（Wharton）Joseph Aresty管理学教授。在此之前，他创立了The Index Group公司并于1969年至1988年担任主席和CEO，该公司专门从事信息技术策略与管理、公司策略管理和商业重组等。他于2007年担任PharMerica Corporation公司董事。他于1990年之2010年担任Sunoco, Inc.公司董事，2003年至2008年担任Hercules, Inc.公司董事。
- Thomas P. Gerrity has served as a director since July 31 2007. Mr. Gerrity serves as a member of the Compensation Committee and the Nominating and Corporate Governance Committee of the Board. Mr. Gerrity was the Dean of the Wharton School of the University of Pennsylvania from July 1990 to June 1999. Since then he has been Professor of Management and Dean Emeritus at the Wharton School of the University of Pennsylvania. Mr. Gerrity also serves as a director of Actua Corporation ACTA, since 1998 and served as a member of the Corporation of the Massachusetts Institute of Technology from 2001-2011. Mr. Gerrity is the Chairman of the Board and General Partner of the Arden Fund I and Fund II, a private real estate investment fund managed by the Arden Group in Philadelphia, Pennsylvania. Mr. Gerrity served as a director of Sunoco, Inc. Mr. Gerrity was the founder and Chief Executive Officer for 19 years of The Index Group, a leader in consulting to many corporations regarding IT strategy and overall corporate strategy and change management.
- Frank E. Collins
-
Frank E. Collins， 自2007年7月31日以来，是一位董事。2008年7月-2009年6月期间，是管理暨提名委员会主席。2001年-2008年2月期间，是Sierra Health Services股份有限公司“Sierra”的行政及法律事务高级副总裁和秘书。Sierra于2008年2月被United Health 集团股份有限公司“United”收购。2008年2月-2012年7月期间，是United的副法律总顾问。他是于1986年加入Sierra并担任法律总顾问以及秘书的。1981-1986年期间，为Kansas城Blue Cross and Blue Shield所聘用，起初担任工作人员法律顾问，1986年初担任助理法律总顾问。他还曾于1979-1981年期间，在Missouri Division of Insurance担任顾问，负责提供保险法律建议和HMO相关的监管问题。他是从Missouri 大学Kansas城法学院获得他的法学博士学位的；是密苏里州（Missouri）律师协会的一位成员。
Frank E. Collins has served as a director since July 31, 2007. Mr. Collins serves as Chair of the Nominating and Governance Committee of the Board and served as a member of the Compensation Committee from June 2008 to June 2009. Mr. Collins was the Senior Vice President, Legal and Administration and Secretary of Sierra Health Services, Inc. ("Sierra") from 2001 to February 2008. Sierra was acquired by United Health Group Incorporated ("United") in February 2008. Mr. Collins now serves as the Deputy General Counsel of United. Mr. Collins joined Sierra in 1986 as General Counsel and Secretary. From 1981 to 1986, Mr. Collins was employed by Blue Cross and Blue Shield of Kansas City, originally as Staff Legal Counsel and in early 1986 as Associate General Counsel. Mr. Collins also served as counsel for the Missouri Division of Insurance from 1979 to 1981, where he was responsible for providing legal advice on insurance and HMO-related regulatory issues. Mr. Collins received his Juris Doctor from the University of Missouri at Kansas City School of Law and is a member of the Missouri Bar Association. - Frank E. Collins， 自2007年7月31日以来，是一位董事。2008年7月-2009年6月期间，是管理暨提名委员会主席。2001年-2008年2月期间，是Sierra Health Services股份有限公司“Sierra”的行政及法律事务高级副总裁和秘书。Sierra于2008年2月被United Health 集团股份有限公司“United”收购。2008年2月-2012年7月期间，是United的副法律总顾问。他是于1986年加入Sierra并担任法律总顾问以及秘书的。1981-1986年期间，为Kansas城Blue Cross and Blue Shield所聘用，起初担任工作人员法律顾问，1986年初担任助理法律总顾问。他还曾于1979-1981年期间，在Missouri Division of Insurance担任顾问，负责提供保险法律建议和HMO相关的监管问题。他是从Missouri 大学Kansas城法学院获得他的法学博士学位的；是密苏里州（Missouri）律师协会的一位成员。
- Frank E. Collins has served as a director since July 31, 2007. Mr. Collins serves as Chair of the Nominating and Governance Committee of the Board and served as a member of the Compensation Committee from June 2008 to June 2009. Mr. Collins was the Senior Vice President, Legal and Administration and Secretary of Sierra Health Services, Inc. ("Sierra") from 2001 to February 2008. Sierra was acquired by United Health Group Incorporated ("United") in February 2008. Mr. Collins now serves as the Deputy General Counsel of United. Mr. Collins joined Sierra in 1986 as General Counsel and Secretary. From 1981 to 1986, Mr. Collins was employed by Blue Cross and Blue Shield of Kansas City, originally as Staff Legal Counsel and in early 1986 as Associate General Counsel. Mr. Collins also served as counsel for the Missouri Division of Insurance from 1979 to 1981, where he was responsible for providing legal advice on insurance and HMO-related regulatory issues. Mr. Collins received his Juris Doctor from the University of Missouri at Kansas City School of Law and is a member of the Missouri Bar Association.
- W. Robert Dahl, Jr.
-
W. Robert Dahl, Jr.， 自2008年7月24日以来，担任董事。目前是审计委员会成员。他是一位私人投资者。曾于2009年9月-2012年3月期间，在一家投资公司- Arrowhawk Capital Partners担任首席运营官。此前，2007年5月-2009年11月期间，在Golden Pond Healthcare股份有限公司担任战略商业开发副总裁和副董事长。1999年4月-2006年6月期间，是一家领先的私有股本公司- Carlyle Group的全球医疗主管，负责该公司在医疗领域的投资。在Carlyle之前，他曾在Credit Suisse First Boston北美（North America）担任医疗投资银行业务联席主管。他还是以下公司的一位董事：Applied Science股份有限公司、Pharm Blue控股有限责任公司、Remedy Partners、Sprout Pharmaceuticals股份有限公司和Virtual Office Works有限责任公司；这些都是私有公司。他是从Middlebury学院获得学士学位，以及从哈佛工商管理研究生院（Harvard Graduate School of Business Administration）获得工商管理硕士学位的。
W. Robert Dahl, Jr. has served as a director since July 24 2008. Mr. Dahl serves as a member of the Audit Committee. Mr. Dahl is currently a private investor. He was the Chief Operating Officer of Arrowhawk Capital Partners, an investment company, from September 2009 until March 2012. Previously, from May 2007 to November 2009 he was the Vice President of Strategic Business Development and Vice Chairman of the Board of Directors of Golden Pond Healthcare, Inc. From April 1999 until June 2006 Mr. Dahl served as the head of Global Healthcare for the Carlyle Group “Carlyle”, a leading private equity firm, where he was responsible for the firm’s investments in the healthcare field. Prior to Carlyle, Mr. Dahl served as co-head of healthcare investment banking in North America at Credit Suisse First Boston. Mr. Dahl is also a director of CertiScan Technologies, Pharm Blue Holdings, Remedy Partners, RJ Health Systems, HealthPrize Technologies and Virtual Office Works, all of which are private companies. Mr. Dahl received a BA from Middlebury College and an MBA from the Harvard Graduate School of Business Administration. - W. Robert Dahl, Jr.， 自2008年7月24日以来，担任董事。目前是审计委员会成员。他是一位私人投资者。曾于2009年9月-2012年3月期间，在一家投资公司- Arrowhawk Capital Partners担任首席运营官。此前，2007年5月-2009年11月期间，在Golden Pond Healthcare股份有限公司担任战略商业开发副总裁和副董事长。1999年4月-2006年6月期间，是一家领先的私有股本公司- Carlyle Group的全球医疗主管，负责该公司在医疗领域的投资。在Carlyle之前，他曾在Credit Suisse First Boston北美（North America）担任医疗投资银行业务联席主管。他还是以下公司的一位董事：Applied Science股份有限公司、Pharm Blue控股有限责任公司、Remedy Partners、Sprout Pharmaceuticals股份有限公司和Virtual Office Works有限责任公司；这些都是私有公司。他是从Middlebury学院获得学士学位，以及从哈佛工商管理研究生院（Harvard Graduate School of Business Administration）获得工商管理硕士学位的。
- W. Robert Dahl, Jr. has served as a director since July 24 2008. Mr. Dahl serves as a member of the Audit Committee. Mr. Dahl is currently a private investor. He was the Chief Operating Officer of Arrowhawk Capital Partners, an investment company, from September 2009 until March 2012. Previously, from May 2007 to November 2009 he was the Vice President of Strategic Business Development and Vice Chairman of the Board of Directors of Golden Pond Healthcare, Inc. From April 1999 until June 2006 Mr. Dahl served as the head of Global Healthcare for the Carlyle Group “Carlyle”, a leading private equity firm, where he was responsible for the firm’s investments in the healthcare field. Prior to Carlyle, Mr. Dahl served as co-head of healthcare investment banking in North America at Credit Suisse First Boston. Mr. Dahl is also a director of CertiScan Technologies, Pharm Blue Holdings, Remedy Partners, RJ Health Systems, HealthPrize Technologies and Virtual Office Works, all of which are private companies. Mr. Dahl received a BA from Middlebury College and an MBA from the Harvard Graduate School of Business Administration.
- Marjorie W. Dorr
-
Marjorie W. Dorr， 自2009年1月22日以来，是一位董事。2010年-2013年期间，曾在薪酬委员会任职；目前是审计委员会的一位成员。2005年-2007年期间，是WellPoint股份有限公司的副执行总裁和战略总监。在WellPoint的时候，她曾担任各种行政职位，包括WellPoint的东北区域SBU总裁和首席执行官，负责数个州的运营。她是通过2004年WellPoint和Anthem股份有限公司的合并加入WellPoint的。在合并的这段时期，她担任Anthem Blue Cross和Blue Shield的东区总裁。她是从Iowa大学获得工商管理学士学位，以及从Chicago大学商学研究生院获得工商管理硕士学位的。
Marjorie W. Dorr has served as a director since January 22 2009. Ms. Dorr serves as a member of the Audit Committee and served on the Compensation Committee between 2010 and 2013. Ms. Dorr served as Executive Vice President and Chief Strategy Officer for WellPoint, Inc. “WellPoint” from 2005 to 2007. Ms. Dorr held various executive positions while at WellPoint including President and Chief Executive Officer of WellPoint’s Northeast Region SBU, where she was responsible for operations in several states. Ms. Dorr joined WellPoint through the merger in 2004 of WellPoint and Anthem, Inc. At the time of the merger, Ms. Dorr served as President of Anthem Blue Cross and Blue Shield’s East region. Ms. Dorr received her bachelor of business administration degree from the University of Iowa and her master of business administration degree from the University of Chicago Graduate School of Business. - Marjorie W. Dorr， 自2009年1月22日以来，是一位董事。2010年-2013年期间，曾在薪酬委员会任职；目前是审计委员会的一位成员。2005年-2007年期间，是WellPoint股份有限公司的副执行总裁和战略总监。在WellPoint的时候，她曾担任各种行政职位，包括WellPoint的东北区域SBU总裁和首席执行官，负责数个州的运营。她是通过2004年WellPoint和Anthem股份有限公司的合并加入WellPoint的。在合并的这段时期，她担任Anthem Blue Cross和Blue Shield的东区总裁。她是从Iowa大学获得工商管理学士学位，以及从Chicago大学商学研究生院获得工商管理硕士学位的。
- Marjorie W. Dorr has served as a director since January 22 2009. Ms. Dorr serves as a member of the Audit Committee and served on the Compensation Committee between 2010 and 2013. Ms. Dorr served as Executive Vice President and Chief Strategy Officer for WellPoint, Inc. “WellPoint” from 2005 to 2007. Ms. Dorr held various executive positions while at WellPoint including President and Chief Executive Officer of WellPoint’s Northeast Region SBU, where she was responsible for operations in several states. Ms. Dorr joined WellPoint through the merger in 2004 of WellPoint and Anthem, Inc. At the time of the merger, Ms. Dorr served as President of Anthem Blue Cross and Blue Shield’s East region. Ms. Dorr received her bachelor of business administration degree from the University of Iowa and her master of business administration degree from the University of Chicago Graduate School of Business.
- Geoffrey G. Meyers
-
Geoffrey G. Meyers， 自2009年11月17日以来，是一位董事；自2011年1月1日以来，是董事长。2010年2月1日，他成为了管理暨提名委员会的一位成员。他是Manor Care股份有限公司已退休的财务总监和首席执行官，1988-2006年期间负责行政和财务管理；以及在1991-1998年期间，是Manor Care股份有限公司的前身- Health Care and Retirement 公司的一位董事。自2011年3月以来，是HCA Holdings股份有限公司的一位董事，以及是该公司审计委员会主席。他目前还是Ohio州西北部一家信托银行- Toledo信托公司的一位董事长。他是从美国西北大学（Northwestern University）获得他的学士学位，以及从Ohio州州立大学获得他的工商管理硕士学位的。
Geoffrey G. Meyers has served as a director since November 17 2009 and as Chairman of the Board since January 1 2011. On February 1 2010 Mr. Meyers became a member of the Nominating and Governance Committee. Mr. Meyers is the retired Chief Financial Officer and Executive Vice President and Treasurer for Manor Care, Inc. where he had responsibility for administration and financial management from 1988 until 2006 and was a director of Health Care and Retirement Corp., a predecessor of Manor Care, Inc., from 1991 to 1998. Mr. Meyers has been a director of HCA Holdings, Inc. and Chairman of is audit committee since March 2011; and he is a director of Welltower Inc. NYSE: HCN since 2014 and is a member of its Audit and Nominating and Goverance Committees. Mr. Meyers is also a Board member of the Trust Company of Toledo, a northwestern Ohio trust bank. He received his BA from Northwestern University and his MBA from The Ohio State University. - Geoffrey G. Meyers， 自2009年11月17日以来，是一位董事；自2011年1月1日以来，是董事长。2010年2月1日，他成为了管理暨提名委员会的一位成员。他是Manor Care股份有限公司已退休的财务总监和首席执行官，1988-2006年期间负责行政和财务管理；以及在1991-1998年期间，是Manor Care股份有限公司的前身- Health Care and Retirement 公司的一位董事。自2011年3月以来，是HCA Holdings股份有限公司的一位董事，以及是该公司审计委员会主席。他目前还是Ohio州西北部一家信托银行- Toledo信托公司的一位董事长。他是从美国西北大学（Northwestern University）获得他的学士学位，以及从Ohio州州立大学获得他的工商管理硕士学位的。
- Geoffrey G. Meyers has served as a director since November 17 2009 and as Chairman of the Board since January 1 2011. On February 1 2010 Mr. Meyers became a member of the Nominating and Governance Committee. Mr. Meyers is the retired Chief Financial Officer and Executive Vice President and Treasurer for Manor Care, Inc. where he had responsibility for administration and financial management from 1988 until 2006 and was a director of Health Care and Retirement Corp., a predecessor of Manor Care, Inc., from 1991 to 1998. Mr. Meyers has been a director of HCA Holdings, Inc. and Chairman of is audit committee since March 2011; and he is a director of Welltower Inc. NYSE: HCN since 2014 and is a member of its Audit and Nominating and Goverance Committees. Mr. Meyers is also a Board member of the Trust Company of Toledo, a northwestern Ohio trust bank. He received his BA from Northwestern University and his MBA from The Ohio State University.
- Robert A. Oakley
-
Robert A. Oakley， 自2008年3月24日以来，是一位董事。目前是审计委员会主席。在Ohio州Columbus市一家全球最大的多元化保险和金融服务机构之一- Nationwide Companies工作了超过25年之后，于2003年从该公司退休。2003年3月-2008年9月期间，在Ohio Casualty公司的董事会任职；2008年1月-2009年8月期间，在First Mercury 金融公司的董事会任职；以及2008年1月-2009年8月期间，在Physicians Assurance公司的董事会任职。他是从Purdue 大学获得他的学士学位，以及从Ohio州州立大学获得他的工商管理硕士学位和金融博士学位的。
Robert A. Oakley has served as a director since March 24 2008. Mr. Oakley serves as the Chairman of the Audit Committee. In 2003 Mr. Oakley retired as Executive Vice President-Finance/CFO after more than 25 years of service with the Columbus, Ohio-based Nationwide Companies, one of the largest diversified insurance and financial services organizations in the world. Mr. Oakley served on the boards of Ohio Casualty Corporation from March 2003 to September 2008 First Mercury Financial Corporation from January 2008 to August 2009 and the Physicians Assurance Corporation from January 2008 to August 2009. He received his BS from Purdue University and both an MBA and Ph.D. in Finance from The Ohio State University. - Robert A. Oakley， 自2008年3月24日以来，是一位董事。目前是审计委员会主席。在Ohio州Columbus市一家全球最大的多元化保险和金融服务机构之一- Nationwide Companies工作了超过25年之后，于2003年从该公司退休。2003年3月-2008年9月期间，在Ohio Casualty公司的董事会任职；2008年1月-2009年8月期间，在First Mercury 金融公司的董事会任职；以及2008年1月-2009年8月期间，在Physicians Assurance公司的董事会任职。他是从Purdue 大学获得他的学士学位，以及从Ohio州州立大学获得他的工商管理硕士学位和金融博士学位的。
- Robert A. Oakley has served as a director since March 24 2008. Mr. Oakley serves as the Chairman of the Audit Committee. In 2003 Mr. Oakley retired as Executive Vice President-Finance/CFO after more than 25 years of service with the Columbus, Ohio-based Nationwide Companies, one of the largest diversified insurance and financial services organizations in the world. Mr. Oakley served on the boards of Ohio Casualty Corporation from March 2003 to September 2008 First Mercury Financial Corporation from January 2008 to August 2009 and the Physicians Assurance Corporation from January 2008 to August 2009. He received his BS from Purdue University and both an MBA and Ph.D. in Finance from The Ohio State University.
- Gregory S. Weishar
-
Gregory S. Weishar， 自2007年1月14日以来，担任本公司的首席执行官。他拥有着医药服务行业超过20年的经验。在加入该公司之前，他从1994年其，在CVS公司的一个处方效益管理独资子公司- PharmaCare Management Services担任首席执行官和总裁。
Gregory S. Weishar has served as our Chief Executive Officer since January 14 2007. He has over 30 years’ experience in the pharmacy services industry. Prior to joining the Company, he was Chief Executive Officer and President of PharmaCare Management Services, a prescription benefit management firm and a wholly-owned subsidiary of CVS Health, since 1994. - Gregory S. Weishar， 自2007年1月14日以来，担任本公司的首席执行官。他拥有着医药服务行业超过20年的经验。在加入该公司之前，他从1994年其，在CVS公司的一个处方效益管理独资子公司- PharmaCare Management Services担任首席执行官和总裁。
- Gregory S. Weishar has served as our Chief Executive Officer since January 14 2007. He has over 30 years’ experience in the pharmacy services industry. Prior to joining the Company, he was Chief Executive Officer and President of PharmaCare Management Services, a prescription benefit management firm and a wholly-owned subsidiary of CVS Health, since 1994.
- Patrick G. LePore
-
Patrick G. LePore， 于2013年1月14日被任命到该董事会。目前是薪酬委员会的一位成员。2007-2012年期间，在Par Pharmaceutical Companies股份有限公司担任董事长。还曾在该公司担任首席执行官一直到该公司于2012年被私募股权投资公司TPG收购。在加入Par Pharmaceutical Companies股份有限公司之前，他曾是Cardinal Health股份有限公司医疗市场部总裁。他是从Villanova大学获得他的学士学位的，目前是该校的一位受托人；以及是从Fairleigh Dickinson大学获得他的工商管理硕士学位的。
Patrick G. LePore was appointed as a Director of the Company in July 2017. On July 1 2018 Mr. LePore succeeded Mr. Farber as Chairman of the Board of Directors. Mr. LePore served as chairman, Chief Executive Officer and president of PAR Pharmaceuticals, Inc., until the company's acquisition by private equity investor TPG in 2012. He remained as chairman of the new company through the sale of the company to Endo Pharmaceuticals. Mr. LePore began his career with Hoffmann LaRoche. Later, he founded Boron LePore and Associates, a medical communications company, which he took public and was eventually sold to Cardinal Health. Mr. LePore is the Vice Chairman of the board of Matinas BioPharm. On September 10 2020 Mr. LePore was appointed as a director of the board of VYNE Therapeutics, Inc. Mr. LePore earned his bachelor's degree from Villanova University and Master of Business Administration from Fairleigh Dickinson University. - Patrick G. LePore， 于2013年1月14日被任命到该董事会。目前是薪酬委员会的一位成员。2007-2012年期间，在Par Pharmaceutical Companies股份有限公司担任董事长。还曾在该公司担任首席执行官一直到该公司于2012年被私募股权投资公司TPG收购。在加入Par Pharmaceutical Companies股份有限公司之前，他曾是Cardinal Health股份有限公司医疗市场部总裁。他是从Villanova大学获得他的学士学位的，目前是该校的一位受托人；以及是从Fairleigh Dickinson大学获得他的工商管理硕士学位的。
- Patrick G. LePore was appointed as a Director of the Company in July 2017. On July 1 2018 Mr. LePore succeeded Mr. Farber as Chairman of the Board of Directors. Mr. LePore served as chairman, Chief Executive Officer and president of PAR Pharmaceuticals, Inc., until the company's acquisition by private equity investor TPG in 2012. He remained as chairman of the new company through the sale of the company to Endo Pharmaceuticals. Mr. LePore began his career with Hoffmann LaRoche. Later, he founded Boron LePore and Associates, a medical communications company, which he took public and was eventually sold to Cardinal Health. Mr. LePore is the Vice Chairman of the board of Matinas BioPharm. On September 10 2020 Mr. LePore was appointed as a director of the board of VYNE Therapeutics, Inc. Mr. LePore earned his bachelor's degree from Villanova University and Master of Business Administration from Fairleigh Dickinson University.
高管简历
中英对照 | 中文 | 英文- Robert E. Dries
RobertE.Dries，1996年至2016年，Dries先生曾在Omnicare Inc.担任多个高级职位，最近于2012年至2016年担任高级副总裁，金融业务。Dries先生在毕马威会计师事务所（KPMG）开始他的职业生涯，在那里他为公共和私人公司提供会计、审计和咨询服务。
Robert E. Dries, From 1996 to 2016 Mr. Dries held several senior positions at Omnicare Inc., most recently serving as Senior Vice President, Financial Operations from 2012 to 2016. Mr. Dries began his career at KPMG, where he provided accounting, auditing and consulting services to both public and private companies.- RobertE.Dries，1996年至2016年，Dries先生曾在Omnicare Inc.担任多个高级职位，最近于2012年至2016年担任高级副总裁，金融业务。Dries先生在毕马威会计师事务所（KPMG）开始他的职业生涯，在那里他为公共和私人公司提供会计、审计和咨询服务。
- Robert E. Dries, From 1996 to 2016 Mr. Dries held several senior positions at Omnicare Inc., most recently serving as Senior Vice President, Financial Operations from 2012 to 2016. Mr. Dries began his career at KPMG, where he provided accounting, auditing and consulting services to both public and private companies.
- Gregory S. Weishar
Gregory S. Weishar， 自2007年1月14日以来，担任本公司的首席执行官。他拥有着医药服务行业超过20年的经验。在加入该公司之前，他从1994年其，在CVS公司的一个处方效益管理独资子公司- PharmaCare Management Services担任首席执行官和总裁。
Gregory S. Weishar has served as our Chief Executive Officer since January 14 2007. He has over 30 years’ experience in the pharmacy services industry. Prior to joining the Company, he was Chief Executive Officer and President of PharmaCare Management Services, a prescription benefit management firm and a wholly-owned subsidiary of CVS Health, since 1994.- Gregory S. Weishar， 自2007年1月14日以来，担任本公司的首席执行官。他拥有着医药服务行业超过20年的经验。在加入该公司之前，他从1994年其，在CVS公司的一个处方效益管理独资子公司- PharmaCare Management Services担任首席执行官和总裁。
- Gregory S. Weishar has served as our Chief Executive Officer since January 14 2007. He has over 30 years’ experience in the pharmacy services industry. Prior to joining the Company, he was Chief Executive Officer and President of PharmaCare Management Services, a prescription benefit management firm and a wholly-owned subsidiary of CVS Health, since 1994.
- Thomas A. Caneris
Thomas A. Caneris， 自2007年8月以来，是本公司的高级副总裁、法律总顾问以及秘书；自2010年以来是首席合规官。在加入该公司之前，他从2004年9月起是Convergys公司的一位法律顾问。
Thomas A. Caneris joined the Company as its Senior Vice President, Human Resces and General Counsel and Secretary in Augt 2019. He was named as an Executive Vice President in Augt 2021. Prior to joining the Company, Mr. Caneris served as Senior Vice President Human Resces, General Counsel & Secretary of PharMerica Corporation, a pharmacy services provider from Augt 2007 to April 2019. Mr. Caneris received his J.D. from the University of Cincinnati College of Law.- Thomas A. Caneris， 自2007年8月以来，是本公司的高级副总裁、法律总顾问以及秘书；自2010年以来是首席合规官。在加入该公司之前，他从2004年9月起是Convergys公司的一位法律顾问。
- Thomas A. Caneris joined the Company as its Senior Vice President, Human Resces and General Counsel and Secretary in Augt 2019. He was named as an Executive Vice President in Augt 2021. Prior to joining the Company, Mr. Caneris served as Senior Vice President Human Resces, General Counsel & Secretary of PharMerica Corporation, a pharmacy services provider from Augt 2007 to April 2019. Mr. Caneris received his J.D. from the University of Cincinnati College of Law.
- Robert A. McKay
Robert A. McKay，自2010年7月以来，是本公司的采购和贸易关系高级副总裁。2007年7月-2010年6月期间，担任销售和营销高级副总裁。在2007年7月加入该公司之前，他曾是CVS公司的一个独资处方效益管理子公司- PharmaCare Management Services的营销和贸易关系副总裁；以及自1995年以来在PharmaCare担任各种职位。他是一位已退休的美国陆军（United States Army）军官。
Robert A. McKay had previously served as Senior Vice President of Sales and Marketing from July 2007 to June 2010. Prior to joining the Company in July 2007 Mr. McKay was Vice President of Marketing and Trade Relations for PharmaCare Management Services, a prescription benefit management firm and a wholly-owned subsidiary of CVS Corporation and held various positions with PharmaCare since 1995. Mr. McKay is a retired United States Army Reserve officer.- Robert A. McKay，自2010年7月以来，是本公司的采购和贸易关系高级副总裁。2007年7月-2010年6月期间，担任销售和营销高级副总裁。在2007年7月加入该公司之前，他曾是CVS公司的一个独资处方效益管理子公司- PharmaCare Management Services的营销和贸易关系副总裁；以及自1995年以来在PharmaCare担任各种职位。他是一位已退休的美国陆军（United States Army）军官。
- Robert A. McKay had previously served as Senior Vice President of Sales and Marketing from July 2007 to June 2010. Prior to joining the Company in July 2007 Mr. McKay was Vice President of Marketing and Trade Relations for PharmaCare Management Services, a prescription benefit management firm and a wholly-owned subsidiary of CVS Corporation and held various positions with PharmaCare since 1995. Mr. McKay is a retired United States Army Reserve officer.
- Berard E. Tomassetti
Berard E. Tomassetti，自2007年7月以来，是本公司的高级副总裁和首席会计官。在加入该公司之前，他曾在医药公司Kindred Healthcare股份有限公司“Kindred”担任了超过6年的首席执行官。在加入Kindred的药房业务之前，他曾在一家凭证验证机构- Aperture工作。他曾在Ernst & Young LLP担任了7年的审计师。
Berard E. Tomassetti has served as the company's Senior Vice President and Chief Accounting Officer since July 2007 and from October 1 2016 to January 30 2017 served as the company's Interim Chief Financial Officer. Prior to joining the Company, Mr. Tomassetti served as the Chief Financial Officer of the Kindred Healthcare, Inc. “Kindred” pharmacy business for over 6 years. Prior to joining Kindred’s pharmacy business, Mr. Tomassetti was affiliated with Aperture, a credentials verification organization. Mr. Tomassetti was an auditor with Ernst & Young LLP for 7 years.- Berard E. Tomassetti，自2007年7月以来，是本公司的高级副总裁和首席会计官。在加入该公司之前，他曾在医药公司Kindred Healthcare股份有限公司“Kindred”担任了超过6年的首席执行官。在加入Kindred的药房业务之前，他曾在一家凭证验证机构- Aperture工作。他曾在Ernst & Young LLP担任了7年的审计师。
- Berard E. Tomassetti has served as the company's Senior Vice President and Chief Accounting Officer since July 2007 and from October 1 2016 to January 30 2017 served as the company's Interim Chief Financial Officer. Prior to joining the Company, Mr. Tomassetti served as the Chief Financial Officer of the Kindred Healthcare, Inc. “Kindred” pharmacy business for over 6 years. Prior to joining Kindred’s pharmacy business, Mr. Tomassetti was affiliated with Aperture, a credentials verification organization. Mr. Tomassetti was an auditor with Ernst & Young LLP for 7 years.
- Suresh Vishnubhatla
Suresh Vishnubhatla，于2011年3月加入该公司并担任技术总监。在加入该公司之前，他从2007年1月起，在Millennium Pharmacy Systems股份有限公司担任高级副总裁和技术总监。在加入Millennium Pharmacy Systems股份有限公司之前，他曾于2000年-2006年期间，在BodyMedia股份有限公司担任各种职位，最后担任产品高级副总裁。
Suresh Vishnubhatla currently serves as the Company’s Executive Vice President of Long-Term Care Operations and from March 2011 to December 2013 served as Chief Technology Officer. Prior to joining the Company, he served as Senior Vice President and Chief Technology Officer of Millennium Pharmacy Systems, Inc. from January 2007. Prior to joining Millennium Pharmacy Systems, Inc., Mr. Vishnubhatla held various positions with BodyMedia, Inc. from 2000 to 2006 finally serving as Senior Vice President, Products.- Suresh Vishnubhatla，于2011年3月加入该公司并担任技术总监。在加入该公司之前，他从2007年1月起，在Millennium Pharmacy Systems股份有限公司担任高级副总裁和技术总监。在加入Millennium Pharmacy Systems股份有限公司之前，他曾于2000年-2006年期间，在BodyMedia股份有限公司担任各种职位，最后担任产品高级副总裁。
- Suresh Vishnubhatla currently serves as the Company’s Executive Vice President of Long-Term Care Operations and from March 2011 to December 2013 served as Chief Technology Officer. Prior to joining the Company, he served as Senior Vice President and Chief Technology Officer of Millennium Pharmacy Systems, Inc. from January 2007. Prior to joining Millennium Pharmacy Systems, Inc., Mr. Vishnubhatla held various positions with BodyMedia, Inc. from 2000 to 2006 finally serving as Senior Vice President, Products.